منابع مشابه
Therapeutic Applications of Monoclonal Antibodies in Multiple Sclerosis
Despite the various therapies available, the use of monoclonal antibodies is a highly specific approach that has only recently been of interest to researchers. The properties of antibodies have led to their use in the treatment of various diseases, including cancer, Alzheimer's disease, diabetes and multiple sclerosis (MS). MS, a chronic inflammatory disease, occurs commonly in young adults. Th...
متن کاملO9: Mechanisms and Therapeutic Options in Multiple Sclerosis
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. Clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. At the moment MS is incurable, thus there is an unmet need for therapeutic options.
متن کاملTherapeutic antibodies in multiple sclerosis.
ment of ever more effective drugs for the treatment of MS. The first immunomodulatory agents to benefit from the development mentioned above, interferon(Avonex , Betaferon/Betaseron , Rebif ) and glatiramer acetate (Copaxone ), have been on the market for more than a decade now and are established, safe, yet only mildly effective treatments for MS. They reduce the frequency of new relapses by...
متن کاملTherapeutic options in multiple sclerosis
Neurology® Clinical Practice 2010;75(Suppl 1):S22–S27 Care of the patient with multiple sclerosis (MS) is becoming increasingly complex, with new symptomatic therapies (e.g., dalfampridine), enhanced use of disease-modifying therapies that are potentially both more efficacious and more risky (e.g., natalizumab, rituximab) than “standard” immunomodulators, the advent of oral disease-modifying th...
متن کامل[Therapeutic strategy against multiple sclerosis].
The pathogenesis of multiple sclerosis (MS) remains to be elucidated and there is no curative therapy against MS, though we have several disease modifying drugs. In this symposium. I introduce several new strategies against development of autoimmune processes and axonal degeneration in MS. Several mechanisms regulate immune system not to attack self components. One of the most potent regulatory...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1989
ISSN: 0032-5473
DOI: 10.1136/pgmj.65.766.606-a